SCHEMBL6927437

SCHEMBL6927437

NS(=O)(=O)c1cc2cc(P(=O)(O)O)c(=O)[nH]c2cc1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA12 O43570 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
CYP2C9 P11712 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GRIA1 P42261 1/20 0.32
GRIA2 P42262 1/20 0.32
GRIA3 P42263 1/20 0.32
GRIA4 P48058 1/20 0.32
EGLN1 Q9GZT9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7652393 0.84 TAS2R14 (0.34) GRIA1GRIA2GRIA3GRIA4EGLN1
SCHEMBL6927156 0.83 DAO (0.33) CA1CA2CA12CA9
SCHEMBL7650389 0.82 KDM4E (0.39) KDM4EALDH1A1LMNACYP2C9
SCHEMBL6923612 0.82 CA1 (0.36) CA1CA2CA12CA4CA6
SCHEMBL7198556 0.81 CA12 (0.33) CA1CA2CA12CA4CA6
SCHEMBL7651833 0.80 KDM4E (0.35) KDM4EALDH1A1CYP2C9SMN1; SMN2EGLN1
SCHEMBL7647528 0.80 KDM4E (0.34) CA12CA9KDM4EALDH1A1
SCHEMBL6927443 0.75 CA12 (0.41) CA1CA2CA12CA4CA6
SCHEMBL7739865 0.74 GRIA1 (0.61) GRIA1GRIA2GRIA3GRIA4
SCHEMBL28748171 0.74 GRIA1 (0.32) GRIA1GRIA2GRIA3GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596709-B1 For treatment of Alzheimer's disease, schizophrenia, amyotrophic lateral sclerosis, and Huntington's chorea LES LABORATOIRES SERVIER (FR) 2003-07-22 US claimed
EP-1125941-B1 Derivatives of 6-sulfamoyl-3-quinolyl phosphonic acids, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2003-04-09 EP claimed
US-6518258-B1 6-sulphamoyl -3-quinolyphosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2003-02-11 US claimed
US-6596709-B1 For treatment of Alzheimer's disease, schizophrenia, amyotrophic lateral sclerosis, and Huntington's chorea LES LABORATOIRES SERVIER (FR) 2003-07-22 US disclosed
US-6518258-B1 6-sulphamoyl -3-quinolyphosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2003-02-11 US disclosed